News & Trends - Medical Technology

Health funds must exercise caution when calculating COVID-19 relief for policyholders

Health Industry Hub | December 13, 2021 |
[Total: 1    Average: 4/5]

MedTech News: Insurers have continued to return profits gained from a reduction in claims during the COVID‑19 pandemic to policyholders, but ongoing restrictions in some states delayed the full return of these profits in 2020-21, the latest ACCC annual report into the private health insurance industry has found.

In the 12 months to June 2021, government-imposed COVID-19 restrictions continued to limit policyholders’ access to non-urgent elective surgery and non-urgent ‘extras’ treatments (including most dental, optical and other health services).

This impact was particularly notable in Victoria, which experienced several local lockdowns during the reporting period, and was also evident to a lesser extent in NSW.

“The ACCC is aware that many insurers have been implementing their commitments to return profits from COVID-19 restrictions to policyholders, primarily through premium credits or direct payments to policyholders, and we support these efforts,” ACCC Deputy Chair Delia Rickard said. 

However, the ACCC is concerned some of the statements made by insurers when announcing relief for policyholders may suggest that they are calculating their total profitability from COVID restrictions too conservatively, by reference only to the value of their ‘deferred claims liability’.

The deferred claims liability refers to money that financial regulators directed insurers to set aside to ensure they will have adequate capital to meet the cost of procedures that were deferred as a result of COVID-19 restrictions.

“The deferred claims liability is not a proxy for total profitability from COVID restrictions, and nor was this ever the intention when financial regulators directed insurers to create a deferred claims liability,” Ms Rickard said.

The ACCC notes that insurers can exclude the value of claims that were missed due to COVID restrictions and are not expected to materialise later (e.g. dental ‘clean and scale’ services) when calculating their deferred claims liability. However, for the purpose of fulfilling their broader commitments made in 2020 not to financially benefit from the pandemic, the ACCC expects insurers to include the value of these claims when calculating their policyholder relief.  

“We expect insurers to return all benefits from procedures that were not performed and are not expected to be performed later. This may be particularly applicable to extras treatment and geographic areas that were subject to extended lockdowns.”

“We will continue to monitor the actions of insurers to return all profits made due to COVID‑19 to policy holders as they promised and report on it in our next annual report on the private health insurance industry,” Ms Rickard said.

The report also noted the proportion of Australians with health insurance has increased for the first time since 2015, which has been attributed to increased community focus on health due to COVID-19. In June 2021, nearly 14 million Australians or approximately 54.3 per cent of the population, had some form of private health insurance, an increase of 1.4 per cent since June 2020.

People holding hospital policies increased across most age groups, but the rate of increase was fastest among those aged 75 and older. In fact, 2020-21 is the first year in which people in their mid to late 70s holding hospital cover outnumbered people in their mid to late 20s with such cover.

This year’s private health insurance average premium increase was the lowest since 2001 at 2.74%. Cumulative premium increases over the past five years to June 2021 continue to outpace wage growth, with average premium increases being more than double inflation (CPI) during the same period. 

Human Resources

PAIG co-chairs reflect on industry progress in D&I with sights set on next phase goals

Health Industry Hub | January 17, 2022 |

Human Resources: In this Health Industry Hub podcast, Medicines Australia’s PAIG (Pharma Australia Inclusion Group) co-chairs reflect on their contribution […]


News & Trends - Medical Technology

MedTech News -

Stryker announces fellowships for medtech partner projects

Health Industry Hub | January 17, 2022 |

MedTech News: Stryker announced two of its partner research projects have secured fellowship funding from the Australian government’s Researcher Exchange […]


News & Trends - Pharmaceuticals

Pharma News - New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

New guidelines recommend Eli Lilly and GSK drugs in treating COVID-19 patients

Health Industry Hub | January 17, 2022 |

Pharma News: Update to international guidelines recommend two new drugs for the treatment of COVID-19. Eli Lilly’s oral JAK inhibitor, […]


News & Trends - Pharmaceuticals

Pharma News -

Novartis shifts focus as CAR T-cell therapy fails to add benefit in non-Hodgkin lymphoma

Health Industry Hub | January 17, 2022 |

Pharma News: Novartis’ chimeric antigen receptor (CAR) T-cell therapy was not found to improve event-free survival over what was seen […]